IDR 54.0
(-1.82%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 218.85 Million | 3.76 Billion | 82.4 Million | 110.37 Million | 513.1 Million | 270.75 Million |
Net Income | 250.04 Million | 3.73 Billion | -4.15 Billion | -2.44 Billion | -38.93 Million | 809.84 Thousand |
Depreciation & Amortization | 507.84 Million | 30.62 Million | 1.25 Billion | 1.52 Billion | 181.97 Million | 178.54 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | 17.58 Million | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -539.03 Million | -17.58 Million | 2.98 Billion | 1.02 Billion | 370.06 Million | -809.84 Thousand |
Investing Cash Flow | -316.46 Million | -263.52 Million | -245.85 Million | -55.94 Million | -317.43 Million | -310.34 Million |
Investments in PPE | -300.84 Million | -262.57 Million | -230.8 Million | -57.91 Million | -512.52 Million | -399.12 Million |
Acquisitions | - | - | 476.73 Thousand | 4.78 Million | 160.6 Million | 92.61 Million |
Investment purchases | - | - | -18.04 Million | -13.01 Million | -6.62 Million | -13.81 Million |
Sales/Maturities of investments | - | - | 2.5 Million | 8.22 Million | 23.86 Million | 12.84 Million |
Other Investing Activities | -15.61 Million | -950.47 Thousand | 18.63 Thousand | 1.97 Million | 17.24 Million | -2.86 Million |
Financing Cash Flow | -145.84 Million | 472.92 Million | 21.54 Million | -150.93 Million | -146.73 Million | 2.29 Million |
Debt repayment | -73.78 Million | -8.78 Million | -69.75 Million | -1.07 Billion | -39.65 Million | -2.39 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 483.39 Million | - | - | - | - |
Other Financing Activities | 3.17 Million | -1.68 Million | 91.29 Million | 925.55 Million | -107.07 Million | 2.39 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 521.68 Million | 54.44 Million | 199.13 Million | 297.41 Million | 251.01 Million | 305.71 Million |
Cash at end of period | 289.84 Million | 521.68 Million | 54.44 Million | 199.13 Million | 297.41 Million | 251.18 Million |
Capital Expenditure | -300.84 Million | -262.57 Million | -230.8 Million | -57.91 Million | -512.52 Million | -399.12 Million |
Effect of forex changes on cash | 11.62 Million | -3.51 Million | -2.78 Million | -1.77 Million | -2.53 Million | -17.23 Million |
Net cash flow / Change in cash | -231.83 Million | 467.24 Million | -144.69 Million | -98.27 Million | 46.39 Million | -54.52 Million |
Free Cash Flow | -81.99 Million | 3.5 Billion | -148.4 Million | 52.45 Million | 574.41 Thousand | -128.37 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -14.61 Million | -87.03 Million | 250.04 Million | 322.43 Million | 4.11 Million | 33.63 Million |
Depreciation & Amortization | 138.29 Million | 151.71 Million | 507.84 Million | 116.32 Million | 136.33 Million | 128.68 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 24.67 Million | 173.74 Million | -539.03 Million | -333.58 Million | -117.58 Million | -47.35 Million |
Investing Cash Flow | -77.48 Million | -81.7 Million | -316.46 Million | -86.76 Million | -78.64 Million | -58.44 Million |
Investments in PPE | -89.56 Million | -86.39 Million | -300.84 Million | -273.49 Million | 103.36 Million | -58.11 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 18.24 Million | -1.7 Million | -15.61 Million | 186.72 Million | -182.01 Million | -324.48 Thousand |
Financing Cash Flow | -62.3 Million | -59.89 Million | -145.84 Million | -85.23 Million | -10.07 Million | -56.32 Million |
Debt repayment | -9.08 Million | -8.4 Million | -73.78 Million | -48.73 Million | -7.02 Million | -17.97 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 633.04 Thousand | 3.91 Million | 3.17 Million | -6.15 Million | -3.05 Million | -38.34 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 227.38 Million | 289.84 Million | 521.68 Million | 351.81 Million | 428.11 Million | 428.23 Million |
Cash at end of period | 229.11 Million | 227.38 Million | 289.84 Million | 289.84 Million | 351.81 Million | 428.11 Million |
Capital Expenditure | -89.56 Million | -86.39 Million | -300.84 Million | -273.49 Million | 103.36 Million | -58.11 Million |
Effect of forex changes on cash | -6.82 Million | -7.57 Million | 11.62 Million | 4.87 Million | -10.44 Million | -326.92 Thousand |
Net cash flow / Change in cash | 1.73 Million | -62.46 Million | -231.83 Million | -61.96 Million | -76.29 Million | -123.37 Thousand |
Free Cash Flow | 58.78 Million | 310.41 Thousand | -81.99 Million | -168.32 Million | 126.24 Million | 56.85 Million |
2814
090370
TRIVENIENT
AWC
EMR
CITYONLINE